Novartis Gets Counterclaims Cut From Heart Drug Patent MDL
A Delaware federal judge has thrown out declaratory judgment counterclaims lodged against Novartis by two generic-drug makers in multidistrict patent litigation over Novartis' heart medication Entresto, determining that the court lacks...To view the full article, register now.
Already a subscriber? Click here to view full article